ChromaDex (CDXC) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision ScienceMarch 19, 2025 | businesswire.comChromaDex (NASDAQ:CDXC) Earns "Buy" Rating from HC WainwrightMarch 19, 2025 | americanbankingnews.comChromaDex's (CDXC) Buy Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $11.00 price target on shares of ChromaDex in a research note on Monday.March 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $2.69 Million Stock Position in ChromaDex Co. (NASDAQ:CDXC)Connor Clark & Lunn Investment Management Ltd. grew its holdings in ChromaDex Co. (NASDAQ:CDXC - Free Report) by 189.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 506,186 shares of the company's stock after purchaMarch 18, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Trading Down 5.6% - Here's WhyChromaDex (NASDAQ:CDXC) Shares Down 5.6% - Here's What HappenedMarch 14, 2025 | marketbeat.comChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025March 13, 2025 | businesswire.comQ1 Earnings Forecast for ChromaDex Issued By HC WainwrightChromaDex Co. (NASDAQ:CDXC - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for ChromaDex in a report issued on Monday, March 10th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings of $0.03 per shaMarch 12, 2025 | marketbeat.comChromaDex to Present at the 37th Annual Roth ConferenceMarch 11, 2025 | businesswire.comChromaDex price target raised to $11 from $8 at H.C. WainwrightMarch 10, 2025 | markets.businessinsider.comChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, HC Wainwright Analyst SaysHC Wainwright increased their price objective on shares of ChromaDex from $8.00 to $11.00 and gave the company a "buy" rating in a research note on Monday.March 10, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Stock Rating Lowered by StockNews.comStockNews.com downgraded shares of ChromaDex from a "strong-buy" rating to a "buy" rating in a research note on Thursday.March 7, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Shares Down 8.1% - What's Next?ChromaDex (NASDAQ:CDXC) Stock Price Down 8.1% - Should You Sell?March 7, 2025 | marketbeat.comRoth Capital Increases Earnings Estimates for ChromaDexChromaDex Co. (NASDAQ:CDXC - Free Report) - Roth Capital upped their FY2025 earnings estimates for ChromaDex in a research note issued to investors on Wednesday, March 5th. Roth Capital analyst S. Mcgowan now anticipates that the company will earn $0.07 per share for the year, up from their previMarch 7, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Price Target Raised to $8.10 at LADENBURG THALM/SH SHLADENBURG THALM/SH SH upped their price objective on shares of ChromaDex from $6.80 to $8.10 and gave the company a "buy" rating in a report on Wednesday.March 6, 2025 | marketbeat.comChromaDex Capitalizes On Longevity Boom, But Valuation Remains HighMarch 6, 2025 | seekingalpha.comChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextMarch 6, 2025 | finance.yahoo.comChromaDex (NASDAQ:CDXC) Sets New 52-Week High - Here's WhyChromaDex (NASDAQ:CDXC) Sets New 1-Year High - Time to Buy?March 6, 2025 | marketbeat.comQ4 2024 Chromadex Corp Earnings CallMarch 6, 2025 | uk.finance.yahoo.comChromaDex Reports Record Revenues Amid ChallengesMarch 5, 2025 | tipranks.comChromaDex Shares Rise After 4Q Earnings BeatMarch 5, 2025 | marketwatch.comChromaDex price target raised to $8.10 from $6.80 at LadenburgMarch 5, 2025 | markets.businessinsider.comChromadex (CDXC) Gets a Buy from Roth MKMMarch 5, 2025 | markets.businessinsider.comChromaDex (NASDAQ:CDXC) Releases Earnings Results, Beats Estimates By $0.01 EPSChromaDex (NASDAQ:CDXC - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. ChromaDex had a return on equity of 4.85% and a net margin of 1.62%.March 5, 2025 | marketbeat.comChromaDex Corporation (NASDAQ:CDXC) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | insidermonkey.comQ4 2024 Chromadex Corp Earnings Call TranscriptMarch 5, 2025 | gurufocus.comChromaDex Corporation (CDXC) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comChromaDex Corporation 2024 Q4 - Results - Earnings Call PresentationMarch 4, 2025 | seekingalpha.comChromaDex sees FY25 revenue growth roughly 18%March 4, 2025 | markets.businessinsider.comChromaDex reports Q4 EPS 9c, consensus 2cMarch 4, 2025 | markets.businessinsider.comChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 ResultsMarch 4, 2025 | businesswire.com218,528 Shares in ChromaDex Co. (NASDAQ:CDXC) Bought by Los Angeles Capital Management LLCLos Angeles Capital Management LLC acquired a new position in shares of ChromaDex Co. (NASDAQ:CDXC - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 218,528 shares of the company's stock, valuMarch 2, 2025 | marketbeat.comChromaDex (CDXC) Projected to Post Earnings on WednesdayChromaDex (NASDAQ:CDXC) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports.February 26, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Upgraded to Strong-Buy at StockNews.comStockNews.com upgraded shares of ChromaDex from a "buy" rating to a "strong-buy" rating in a research report on Monday.February 25, 2025 | marketbeat.comChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025February 25, 2025 | businesswire.comShort Interest in ChromaDex Co. (NASDAQ:CDXC) Rises By 6.0%ChromaDex Co. (NASDAQ:CDXC - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 2,110,000 shares, a growth of 6.0% from the January 15th total of 1,990,000 shares. Based on an average trading volume of 624,900 shares, the short-interest ratio is currently 3.4 days. Approximately 4.4% of the company's shares are short sold.February 18, 2025 | marketbeat.comShould Weakness in ChromaDex Corporation's (NASDAQ:CDXC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?February 15, 2025 | finance.yahoo.comShould Weakness in ChromaDex Corporation's (NASDAQ:CDXC) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?February 15, 2025 | finance.yahoo.com50,000 Shares in ChromaDex Co. (NASDAQ:CDXC) Acquired by Sargent Investment Group LLCSargent Investment Group LLC purchased a new stake in shares of ChromaDex Co. (NASDAQ:CDXC - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 50,000 shares of the company's stock, valued at approximateFebruary 6, 2025 | marketbeat.comChromaDex Co. (NASDAQ:CDXC) Sees Large Increase in Short InterestChromaDex Co. (NASDAQ:CDXC - Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 2,070,000 shares, a growth of 6.7% from the December 31st total of 1,940,000 shares. Based on an average daily volume of 1,270,000 shares, the days-to-cover ratio is currently 1.6 days. Approximately 4.3% of the shares of the company are sold short.February 3, 2025 | marketbeat.comUS Growth Companies With High Insider Ownership January 2025January 24, 2025 | finance.yahoo.comBarclays PLC Grows Stock Position in ChromaDex Co. (NASDAQ:CDXC)Barclays PLC increased its holdings in ChromaDex Co. (NASDAQ:CDXC - Free Report) by 322.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 70,072 shares of the company's stock after acquiring an additional 53,472 shares during the period. Barclays PLC ownedJanuary 21, 2025 | marketbeat.comShort Interest in ChromaDex Co. (NASDAQ:CDXC) Grows By 6.7%ChromaDex Co. (NASDAQ:CDXC - Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 2,070,000 shares, a growth of 6.7% from the December 15th total of 1,940,000 shares. Based on an average trading volume of 1,270,000 shares, the days-to-cover ratio is currently 1.6 days. Approximately 4.3% of the shares of the company are short sold.January 19, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Rating Lowered to "Buy" at StockNews.comStockNews.com downgraded ChromaDex from a "strong-buy" rating to a "buy" rating in a report on Wednesday.January 15, 2025 | marketbeat.comChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average - Here's What HappenedChromaDex (NASDAQ:CDXC) Stock Passes Above 200-Day Moving Average - Should You Sell?January 14, 2025 | marketbeat.comChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025January 6, 2025 | businesswire.comChromaDex (NASDAQ:CDXC) Shares Cross Above 200-Day Moving Average - Here's What HappenedChromaDex (NASDAQ:CDXC) Share Price Crosses Above 200-Day Moving Average - Time to Sell?January 2, 2025 | marketbeat.comStockNews.com Upgrades ChromaDex (NASDAQ:CDXC) to "Strong-Buy"StockNews.com upgraded shares of ChromaDex from a "buy" rating to a "strong-buy" rating in a report on Wednesday.December 25, 2024 | marketbeat.comChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.comStockNews.com cut ChromaDex from a "strong-buy" rating to a "buy" rating in a research note on Tuesday.December 17, 2024 | marketbeat.comChromaDex Co. (NASDAQ:CDXC) Director Frank L. Jaksch, Jr. Sells 37,161 SharesDecember 14, 2024 | insidertrades.comFrank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) StockChromaDex Co. (NASDAQ:CDXC - Get Free Report) Director Frank L. Jaksch, Jr. sold 37,161 shares of ChromaDex stock in a transaction on Friday, December 13th. The stock was sold at an average price of $6.19, for a total transaction of $230,026.59. Following the completion of the sale, the director now owns 244,179 shares of the company's stock, valued at approximately $1,511,468.01. This trade represents a 13.21 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 13, 2024 | marketbeat.com Remove Ads Get ChromaDex News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXC and its competitors with MarketBeat's FREE daily newsletter. Email Address CDXC Media Mentions By Week CDXC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDXC News Sentiment▼0.630.68▲Average Medical News Sentiment CDXC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDXC Articles This Week▼33▲CDXC Articles Average Week Remove Ads Get ChromaDex News Delivered to You Automatically Sign up to receive the latest news and ratings for CDXC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IBRX News Today BEAM News Today VCEL News Today MIRM News Today EWTX News Today CNTA News Today KYMR News Today CGON News Today DNLI News Today BLTE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDXC) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ChromaDex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ChromaDex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDXC Stock Free CDXC Stock Alerts